Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 7/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | THPO | P40225 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6365168 | 0.95 | APP (0.48) | APPGRM5NPC1RAB9ACYP1A2 | |
| SCHEMBL17536641 | 0.90 | GRM5 (0.39) | APPGRM5NPC1RAB9ACYP1A2 | |
| SCHEMBL17552564 | 0.88 | ALDH1A1 (0.42) | APPGRM5NPC1RAB9ACYP1A2 | |
| SCHEMBL17552562 | 0.86 | PYCR1 (0.37) | APPGRM5NPC1RAB9ACYP1A2 | |
| SCHEMBL17552567 | 0.86 | GRM5 (0.37) | APPGRM5NPC1RAB9ACYP1A2 | |
| SCHEMBL17536625 | 0.83 | ADK (0.43) | APPGRM5NPC1RAB9AMEN1 | |
| SCHEMBL17536624 | 0.83 | APP (0.46) | APPGRM5NPC1RAB9AKDM4E | |
| SCHEMBL17536620 | 0.83 | GRM5 (0.47) | GRM5CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL3947297 | 0.83 | ESR1 (0.42) | APPGRM5NPC1RAB9ACYP1A2 | |
| SCHEMBL6365163 | 0.82 | APP (0.48) | APPGRM5NPC1RAB9ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3189063-B1 | BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS | CALIFORNIA INST OF TECHN (US) | 2019-08-14 | — | — | EP | disclosed |
| US-10072030-B2 | Base-catalyzed silylation of terminal alkyne C—H bonds | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-09-11 | — | — | US | disclosed |
| EP-3189063-A1 | BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS | California Institute of Technology (US) | 2017-07-12 | — | — | EP | disclosed |
| US-20170088563-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | NATIONAL SCIENCE FOUNDATION | 2017-03-30 | — | — | US | disclosed |
| US-20170088563-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | NATIONAL SCIENCE FOUNDATION | 2017-03-30 | — | — | US | disclosed |
| US-9556206-B2 | Base-catalyzed silylation of terminal alkyne C—H bonds | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2017-01-31 | — | — | US | disclosed |
| WO-2016036685-A1 | BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-03-10 | — | — | WO | disclosed |
| WO-2016036685-A1 | BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-03-10 | — | — | WO | disclosed |
| US-20160060278-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-03-03 | — | — | US | disclosed |
| US-20160060278-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060278-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | ALKBH3, CA3, ALKBH2 | APP 4614/4885GRM5 3797/4885NPC1 1295/4885 |
| US-20170088563-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | ALKBH3, CA3, ALKBH2 | APP 4664/4885GRM5 4034/4885NPC1 1349/4885 |
| US-10072030-B2 | Base-catalyzed silylation of terminal alkyne C—H bonds | ALKBH3, CA3, ALKBH2 | APP 4618/4885GRM5 4027/4885NPC1 1351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.